within Pharmacolibrary.Drugs.ATC.N;

model N06BX18
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.067,
    Cl             = 66 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,
    adminCount     = 1,
    Vd             = 0.287,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.002,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Vinpocetine is a synthetic derivative of the vincamine alkaloid obtained from the periwinkle plant Vinca minor. It is used as a cognitive enhancer, mainly for memory improvement and neuroprotective purposes in aging-related cognitive impairment and cerebrovascular disorders. Vinpocetine is not approved by the FDA for therapeutic use in the United States, but is used in some countries as a prescription medication and in others as a dietary supplement.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters as reported in healthy adult volunteers following a single oral dose.</p><h4>References</h4><ol><li><p>Sozański, T, et al., &amp; Szeląg, A (2011). Omeprazole does not change the oral bioavailability or pharmacokinetics of vinpocetine in rats. <i>Pharmacological reports : PR</i> 63(5) 1258–1263. DOI:<a href=&quot;https://doi.org/10.1016/s1734-1140(11)70648-x&quot;>10.1016/s1734-1140(11)70648-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22180371/&quot;>https://pubmed.ncbi.nlm.nih.gov/22180371</a></p></li><li><p>Miskolczi, P, et al., &amp; Vereczkey, L (1990). Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans. <i>European journal of drug metabolism and pharmacokinetics</i> 15(1) 1–5. DOI:<a href=&quot;https://doi.org/10.1007/BF03190120&quot;>10.1007/BF03190120</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2384112/&quot;>https://pubmed.ncbi.nlm.nih.gov/2384112</a></p></li><li><p>Vereczkey, L, et al., &amp; Szporny, L (1979). Pharmacokinetics of vinpocetine in humans. <i>Arzneimittel-Forschung</i> 29(6) 957–960. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/582791/&quot;>https://pubmed.ncbi.nlm.nih.gov/582791</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N06BX18;
